Aurobindo Pharma consolidated net profit declines 4.02% in the March 2017 quarter

Sales decline 2.50% to Rs 3582.13 crore

Net profit of Aurobindo Pharma declined 4.02% to Rs 532.45 crore in the quarter ended March 2017 as against Rs 554.77 crore during the previous quarter ended March 2016. Sales declined 2.50% to Rs 3582.13 crore in the quarter ended March 2017 as against Rs 3673.87 crore during the previous quarter ended March 2016.

For the full year,net profit rose 13.66% to Rs 2301.67 crore in the year ended March 2017 as against Rs 2025.09 crore during the previous year ended March 2016. Sales rose 8.28% to Rs 14844.79 crore in the year ended March 2017 as against Rs 13709.75 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales3582.133673.87 -2 14844.7913709.75 8 OPM %20.1323.43 -23.1322.06 - PBDT749.42872.27 -14 3488.473136.67 11 PBT649.37760.87 -15 3060.842744.30 12 NP532.45554.77 -4 2301.672025.09 14

Powered by Capital Market - Live News